← FDA Drug Approvals (Drugs@FDA)

BREXPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2023-11-20

Drug application

FDA Application #

ANDA213669

Application type

Abbreviated New Drug Application (Generic)

Brand name

BREXPIPRAZOLE

Generic name

Brexpiprazole

Active ingredients

BREXPIPRAZOLE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

HETERO LABS LTD V

First approval

2023-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown